Last reviewed · How we verify
Intravenous Infusion of Diclofenac Sodium
Intravenous Infusion of Diclofenac Sodium is a Small molecule drug developed by A.O.U. Città della Salute e della Scienza. It is currently FDA-approved.
At a glance
| Generic name | Intravenous Infusion of Diclofenac Sodium |
|---|---|
| Sponsor | A.O.U. Città della Salute e della Scienza |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Peripheral Nerve Blocks in Total Knee Arthroplasty (NA)
- Delirium in Elderly Patients With Trauma of the Hip (PHASE4)
- Opioid-free Analgesia for the Management of Acute Post-operative Pain Following Caesarean Section (NA)
- Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium (PHASE4)
- Sedation for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (NA)
- Evidence Based Management of Acute Biliary Pancreatitis
- Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma (NA)
- Dexmedetomidine and Desflurane Consumption (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Infusion of Diclofenac Sodium CI brief — competitive landscape report
- Intravenous Infusion of Diclofenac Sodium updates RSS · CI watch RSS
- A.O.U. Città della Salute e della Scienza portfolio CI
Frequently asked questions about Intravenous Infusion of Diclofenac Sodium
What is Intravenous Infusion of Diclofenac Sodium?
Intravenous Infusion of Diclofenac Sodium is a Small molecule drug developed by A.O.U. Città della Salute e della Scienza.
Who makes Intravenous Infusion of Diclofenac Sodium?
Intravenous Infusion of Diclofenac Sodium is developed and marketed by A.O.U. Città della Salute e della Scienza (see full A.O.U. Città della Salute e della Scienza pipeline at /company/a-o-u-citt-della-salute-e-della-scienza).
What development phase is Intravenous Infusion of Diclofenac Sodium in?
Intravenous Infusion of Diclofenac Sodium is FDA-approved (marketed).